← Open Payments lookup

BREA SWIHART: Open Payments

NPI 1659669042 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,400 in 23 payments from 10 companies in 2025. Trend: 2023 $1,350 · 2024 $610 · 2025 $1,400

Consulting: $800Food & beverage: $588Education: $12
CompanyPaymentsAmount
Celltrion USA Inc.1$800
Madrigal Pharmaceuticals6$250
Gilead Sciences, Inc.4$85
Takeda Pharmaceuticals U.S.A., Inc.3$76
ABBVIE INC.3$54
Lilly USA, LLC2$40
Aimmune Therapeutics, Inc.1$33
Ipsen Biopharmaceuticals, Inc1$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Novo Nordisk Inc1$14

Products named: ZYMFENTRA, REZDIFFRA, ENTYVIO, OMVOH, RINVOQ, ZENPEP, IQIRVO, XIFAXAN.

Industry payments across ME — which companies pay providers there.